ACN Newswire Everest Medicines Presents Positive Results from Phase 1b/2a Clinical Trial of EVER001 for Primary Membranous Nephropathy at ERA 2025 adminខែមិថុនា 9, 2025 HONG KONG, Jun 9, 2025 - (ACN ...
